Abstract
In this Viewpoint, Drs Doria and Briani highlight recent advances in efforts to improve the long-term prognosis of patients with systemic lupus erythematosus. The strategies discussed aim to prevent both the occurrence of the disease and its complications.
MeSH terms
-
Antibodies, Antinuclear / blood
-
Antibodies, Antiphospholipid / blood
-
Humans
-
Lupus Erythematosus, Systemic / immunology
-
Lupus Erythematosus, Systemic / prevention & control*
-
Primary Prevention / methods*
-
Thromboembolism / prevention & control
Substances
-
Antibodies, Antinuclear
-
Antibodies, Antiphospholipid